drugset / Press release
Emergent BioSolutions Initiates Phase 2 Clinical Study to Evaluate FLU-IGIV to Treat Serious Influenza A Infection
2018-01-04 · Emergent BioSolutions · original emergentbiosolutions.com ↗
010418 - EBS Initiates Phase 2 for FLU-IGIV FINAL.pdf 201.6 KB
The release as fetched from its publisher. emergentbiosolutions.com ↗